71 related articles for article (PubMed ID: 34454947)
1. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells.
Jung YY; Baek SH; Narula AS; Namjoshi OA; Blough BE; Ahn KS
Life Sci; 2021 Nov; 284():119893. PubMed ID: 34454947
[TBL] [Abstract][Full Text] [Related]
2. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.
Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
[TBL] [Abstract][Full Text] [Related]
3. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.
Su YL; Luo HL; Huang CC; Liu TT; Huang EY; Sung MT; Lin JJ; Chiang PH; Chen YT; Kang CH; Cheng YT
Cells; 2020 Mar; 9(4):. PubMed ID: 32225123
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of PKCζ/Pard3/Pard6b is responsible for lung adenocarcinoma cell EMT and invasion.
Zhou Q; Dai J; Chen T; Dada LA; Zhang X; Zhang W; DeCamp MM; Winn RA; Sznajder JI; Zhou G
Cell Signal; 2017 Oct; 38():49-59. PubMed ID: 28652146
[TBL] [Abstract][Full Text] [Related]
6. Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells.
Lou C; Zhang F; Yang M; Zhao J; Zeng W; Fang X; Zhang Y; Zhang C; Liang W
PLoS One; 2012; 7(12):e50956. PubMed ID: 23300530
[TBL] [Abstract][Full Text] [Related]
7. Norcycloartocarpin targets Akt and suppresses Akt-dependent survival and epithelial-mesenchymal transition in lung cancer cells.
Nonpanya N; Sanookpan K; Joyjamras K; Wichadakul D; Sritularak B; Chaotham C; Chanvorachote P
PLoS One; 2021; 16(8):e0254929. PubMed ID: 34383763
[TBL] [Abstract][Full Text] [Related]
8. Regulatory roles of osteopontin in human lung cancer cell epithelial-to-mesenchymal transitions and responses.
Shi L; Hou J; Wang L; Fu H; Zhang Y; Song Y; Wang X
Clin Transl Med; 2021 Jul; 11(7):e486. PubMed ID: 34323425
[TBL] [Abstract][Full Text] [Related]
9. Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell.
Li X; Zhao X; Song W; Tian Z; Yang L; Niu Q; Zhang Q; Xie M; Zhou B; Xu Y; Wu J; Zhang C
Yonsei Med J; 2018 Jan; 59(1):20-27. PubMed ID: 29214772
[TBL] [Abstract][Full Text] [Related]
10. TWIST2 inhibits EMT and induces oxidative stress in lung cancer cells by regulating the FGF21-mediated AMPK/mTOR pathway.
Song Y; Zhang W; Zhang J; You Z; Hu T; Shao G; Zhang Z; Xu Z; Yu X
Exp Cell Res; 2021 Aug; 405(1):112661. PubMed ID: 34044016
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Notch1 and AKT mediated epithelial to mesenchymal transition by Verrucarin J in metastatic colon cancer.
Pal D; Tyagi A; Chandrasekaran B; Alattasi H; Ankem MK; Sharma AK; Damodaran C
Cell Death Dis; 2018 Jul; 9(8):798. PubMed ID: 30038258
[TBL] [Abstract][Full Text] [Related]
12. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype.
Keshamouni VG; Michailidis G; Grasso CS; Anthwal S; Strahler JR; Walker A; Arenberg DA; Reddy RC; Akulapalli S; Thannickal VJ; Standiford TJ; Andrews PC; Omenn GS
J Proteome Res; 2006 May; 5(5):1143-54. PubMed ID: 16674103
[TBL] [Abstract][Full Text] [Related]
13. Palmatine inhibits growth and invasion in prostate cancer cell: Potential role for rpS6/NFκB/FLIP.
Hambright HG; Batth IS; Xie J; Ghosh R; Kumar AP
Mol Carcinog; 2015 Oct; 54(10):1227-34. PubMed ID: 25043857
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition and NF-kB pathways are promoted by a mutant form of DDB2, unable to bind PCNA, in UV-damaged human cells.
Perucca P; Bassi E; Vetro M; Tricarico A; Prosperi E; Stivala LA; Cazzalini O
BMC Cancer; 2024 May; 24(1):616. PubMed ID: 38773406
[TBL] [Abstract][Full Text] [Related]
15. YAP1 controls the N-cadherin-mediated tumor-stroma interaction in melanoma progression.
Xiao Y; Zhou L; Andl T; Zhang Y
Oncogene; 2024 Mar; 43(12):884-898. PubMed ID: 38308096
[TBL] [Abstract][Full Text] [Related]
16. MIG-7 and phosphorylated prohibitin coordinately regulate lung cancer invasion/metastasis.
Ho MY; Liang CM; Liang SM
Oncotarget; 2015 Jan; 6(1):381-93. PubMed ID: 25575814
[TBL] [Abstract][Full Text] [Related]
17. PI3K/AKT pathway as a pivotal regulator of epithelial-mesenchymal transition in lung tumor cells.
Moghbeli M
Cancer Cell Int; 2024 May; 24(1):165. PubMed ID: 38730433
[TBL] [Abstract][Full Text] [Related]
18. Vitamin A Status Modulates Epithelial Mesenchymal Transition in the Lung: The Role of Furin.
Cabezuelo MT; Torres L; Ortiz-Zapater E; López-Rodas G; Marín MP; Timoneda J; Viña JR; Zaragozá R; Barber T
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674868
[TBL] [Abstract][Full Text] [Related]
19. Suppression of JAK2/STAT3 Pathway by Notoginsenoside R1 Reduces Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer.
Wan M; Yu H; Zhai H
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38565774
[TBL] [Abstract][Full Text] [Related]
20. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
Ebrahimi N; Manavi MS; Faghihkhorasani F; Fakhr SS; Baei FJ; Khorasani FF; Zare MM; Far NP; Rezaei-Tazangi F; Ren J; Reiter RJ; Nabavi N; Aref AR; Chen C; Ertas YN; Lu Q
Cancer Metastasis Rev; 2024 Mar; 43(1):457-479. PubMed ID: 38227149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
